Gilead results beat Street estimates as demand grows for HIV drug

By

Gilead results beat Street estimates as demand grows for HIV drug

Gilead Sciences beat Wall Street estimates for second-quarter revenue and profit on Tuesday, driven by higher sales of HIV treatments.

Source: Business News –

MustHaves.LA a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.